Avadel Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2024 | 600,000 | $7.87 M | 0.00% | 0.62% |
| KNOTT DAVID M JR | 11/13/2024 | 332,000 | $4.35 M | -0.30% | 0.34% |
| SCHULHOFF & CO INC | 11/06/2024 | 137,000 | $1.80 M | 0.00% | 0.14% |
| 1620 INVESTMENT ADVISORS, INC. | 10/25/2024 | 1,000 | $13,115 | 0.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 11/06/2024 | 1 | $16 | 0.00% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/08/2024 | 0 | $0 | -100.00% | 0.00% |
| VIVO CAPITAL, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TRI LOCUM PARTNERS LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Avadel Pharmaceuticals plcinstitutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Avadel Pharmaceuticals plc. The most heavily invested institutionals were:
Knoll Capital Management, LLC: 600,000
Knott David M Jr: 332,000
SCHULHOFF & CO INC: 137,000
1620 INVESTMENT ADVISORS, INC.: 1,000
HUNTINGTON NATIONAL BANK: 1
Tri Locum Partners LP: 0
1.11% of Avadel Pharmaceuticals plc stock is owned by institutional investors.
Institutional investors have bought a total of 8.08 M shares in the last 24 months. This purchase volume represents approximately $85.17 M in transactions.